Fund moves
64 tracked managers disclosed the same change for Q4 2025. From a 13F filed Feb 17, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jan 23, 2025 · Filed Jan 27, 2026
CVS Health's and President, Aetna paid $1.3K out of pocket for CVS Health shares. 1 other person at CVS Health bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$1,289
Shares × reported transaction price
<$25K
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals less than 1% of the average reported total pay of the company's named executive officers other than the CEO, fiscal 2024 ($9.78M)
An average across the officers named in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-04-03. This person may not be one of them, so it is not their own pay. A size comparison, not a judgement
78 days after results of Nov 6, 2024, 20 days before results of Feb 12, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
Bought 78 days after CVS's last results announcement; 89% of its insiders' purchases since 2018 were made within 30 days after one. Steven H Nelson's first open-market purchase of CVS in filings since 2006
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
A securities lawsuit naming the company as a defendant was filed on Jul 12, 2024 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.
Nixon v. CVS Health Corporation, docket 1:24-cv-05303, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.6% | −1.3% | +3.0% |
| 30 days | +7.9% | −1.4% | +9.3% |
| 90 days | +9.4% | +2.3% | +7.0% |
| 180 days | +44.6% | +6.3% | +38.4% |
Past results only. Not a forecast.
Fund moves
64 tracked managers disclosed the same change for Q4 2025. From a 13F filed Feb 17, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Fund moves
81 tracked managers disclosed the same change for Q4 2025. From a 13F filed Feb 17, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Fund moves
20 tracked managers disclosed the same change for Q4 2025. From a 13F filed Feb 17, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.